Published on 07 April 2016
Low-cost generic drug programs in the US: implications for payers and researchers
Author(s): Joshua D Brown, PharmD, MS
generic medicines, low-cost generic drug programs, quality assessment, United States healthcare system
DOI: 10.5639/gabij.2016.0501.003
4.750 views